CYP19A1 and breast carcinoma: Friesenhengst et al. (11) analyzed the expression of CYP19A1 mRNA in breast cancer tumors and showed that expression levels were significantly elevated in postmenopausal breast cancer patients with an initial diagnosis >50 years.